Diagnosing and Characterizing Chronic Kidney Disease with Machine Learning: The Value of Clinical Patient Characteristics as Evidenced from an Open Dataset

Applying artificial intelligence (AI) and machine learning for chronic kidney disease (CKD) diagnostics and characterization has the potential to improve the standard of patient care through accurate and early detection, as well as providing a more detailed understanding of the condition. This study employed reproducible validation of AI technology with public domain software applied to CKD diagnostics on a publicly available CKD dataset acquired from 400 patients. The approach presented includes patient-specific symptomatic variables and demonstrates performance improvements associated with this approach. Our best-performing AI models, which include patient symptom variables, achieve predictive accuracies ranging from 99.4 to 100% across both hold-out and 5-fold validation with the light gradient boosting machine. We demonstrate that the exclusion of patient symptom variables reduces model performance in line with the literature on the same dataset. We also provide an unsupervised learning cluster analysis to help interpret variability among, and characterize the population of, patients with CKD.

Authors

Institutions

Publication Details

Journal
Electronics
Published
2024-11-04
DOI
https://doi.org/10.3390/electronics13214326
Citations
7
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
2.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnosing and Characterizing Chronic Kidney Disease with Machine Learning: The Value of Clinical Patient Characteristics as Evidenced from an Open Dataset

Juan Carlos Figueroa, Derek Berger, Jacob Levman, Patrick Etim et al.
7 citations
Electronics
Chronic Kidney Disease and Diabetes
2.37
article

Diagnosing and Characterizing Chronic Kidney Disease with Machine Learning: The Value of Clinical Patient Characteristics as Evidenced from an Open Dataset

Juan Carlos Figueroa, Derek Berger, Jacob Levman, Patrick Etim, Adithyan Karanathu Shibu
article en
7 citations

Abstract

Applying artificial intelligence (AI) and machine learning for chronic kidney disease (CKD) diagnostics and characterization has the potential to improve the standard of patient care through accurate and early detection, as well as providing a more detailed understanding of the condition. This study employed reproducible validation of AI technology with public domain software applied to CKD diagnostics on a publicly available CKD dataset acquired from 400 patients. The approach presented includes patient-specific symptomatic variables and demonstrates performance improvements associated with this approach. Our best-performing AI models, which include patient symptom variables, achieve predictive accuracies ranging from 99.4 to 100% across both hold-out and 5-fold validation with the light gradient boosting machine. We demonstrate that the exclusion of patient symptom variables reduces model performance in line with the literature on the same dataset. We also provide an unsupervised learning cluster analysis to help interpret variability among, and characterize the population of, patients with CKD.

ElectronicsVol. 13(21)
St. Francis Xavier University (CA), Nova Scotia Health Authority (CA)
Compute Canada, Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada
Openalex Percentile: Top 9%
Chronic Kidney Disease and Diabetes
2.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.